KALA BIO, Inc. (KALA) stock
KALANasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.43−0.40 (-10.44%)
Close on Nov 17, 2026Market cap $66.34MP/E –Yield –
Kala Bio price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Kala Bio's price to sales ratio was 6.9× on Apr 28, 2023, against 3.8× a year earlier. Over the last 3 years it ranged from 1.1× to 116.7×, with a median of 15.7×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2023 | Apr 28, 2023 | 6.9× | −2.9 |
| 2022 | Dec 30, 2022 | 9.8× | +3.0 |
| 2021 | Dec 31, 2021 | 6.8× | −64.9 |
| 2020 | Dec 31, 2020 | 71.7× | – |
See a number that looks wrong?